Positively Sharing

The United States has approved a twice-a-year jab that almost entirely protects against HIV in what’s being hailed as a “breakthrough moment” for efforts to curb the virus.

Reading Time: minute

Lenacapavir was developed by the US drug company Gilead - Nardus Engelbrecht/AP

The United States has approved a twice-a-year jab that almost entirely protects against HIV in what’s being hailed as a “breakthrough moment” for efforts to curb the virus.   Read More

Exit mobile version